Jana Wattar | Pharmacology | Women Researcher Award

Published on by Academic Achievements

Women Researcher Award

Jana K. Al Wattar
Lebanese International University,  Lebanon
Jana K. Al Wattar
Affiliation Lebanese International University
Country Lebanon
Scopus ID 56999102300
Documents 9
Citations 172
h-index 5
Subject Area Pharmacology, Toxicology and Pharmaceutical Science
Event International Academic Achievements & Awards

Jana K. Al Wattar is a Lebanese pharmaceutical scientist, academic researcher, and Assistant Professor specializing in pharmaceutical sciences, nanotechnology-based drug delivery systems, and translational nanomedicine. Her research primarily focuses on smart lipid-based nanocarriers for cancer therapeutics and neurodegenerative disorders, with emphasis on enhancing therapeutic efficacy, improving drug bioavailability, and overcoming multidrug resistance mechanisms.[1]

Over more than a decade of academic and professional engagement, Dr. Al Wattar has contributed extensively to pharmaceutical education, interdisciplinary nanomedicine research, and international scientific collaboration. Her work integrates pharmaceutical technology, nanotechnology, biotechnology, and biomedical innovation through collaborative partnerships across Lebanon, the Gulf region, and international academic institutions.[2]

Abstract

Jana K. Al Wattar has established a distinguished research profile in pharmaceutical sciences with specialization in nanotechnology-based therapeutic delivery systems for oncology and neurological disorders. Her scientific contributions encompass the formulation, optimization, and characterization of smart nanocarriers, including nanovesicles, nanosponge systems, liposomal nanohybrids, electrohydrodynamic nanofibers, and stimuli-responsive drug delivery platforms.[3]

Her work demonstrates interdisciplinary integration of pharmaceutical technology, nanomedicine, biomaterials, and translational therapeutics. In addition to publishing in internationally recognized journals, she has actively contributed to scientific conferences, secured competitive research grants, supervised collaborative projects, and established institutional research partnerships across the Middle East and beyond.[4]

Keywords

Nanomedicine; Pharmaceutical Technology; Drug Delivery Systems; Lipid Nanocarriers; Cancer Therapeutics; Neurodegenerative Disorders; Smart Nanovesicles; Nanotechnology; Biomaterials; Pharmaceutical Biotechnology; Liposomal Systems; Targeted Drug Delivery; Tissue Engineering; Translational Medicine; Pharmaceutical Sciences

Introduction

Advances in nanotechnology and pharmaceutical sciences have transformed the development of targeted therapeutic systems for complex diseases including cancer and neurodegenerative disorders. Researchers in pharmaceutical nanotechnology contribute significantly to improving therapeutic outcomes through innovative drug delivery systems that enhance bioavailability, stability, specificity, and patient safety. Dr. Jana K. Al Wattar has contributed to this evolving field through sustained academic research focused on nanocarrier engineering, smart drug delivery systems, and translational pharmaceutical applications.[5]

Her research vision aims to establish a translational nanomedicine platform in the Levant region that addresses unmet therapeutic challenges associated with drug resistance, poor bioavailability, and targeted treatment delivery. Her academic and scientific activities demonstrate commitment to regional research development, scientific leadership, and interdisciplinary collaboration.

Research Profile

Dr. Al Wattar currently serves as a Full-time Assistant Professor in the Department of Pharmaceutical Sciences at Lebanese International University in Beirut, Lebanon. Her teaching portfolio includes pharmaceutics, dosage forms, pharmaceutical calculations, physical pharmacy, compounding laboratories, biotechnology laboratories, and pharmacy practice experience courses.

Her academic experience spans more than twelve years in higher education, during which she has contributed to undergraduate and postgraduate mentorship, pharmaceutical curriculum development, and scientific supervision. Prior to her current appointment, she served as Lecturer Assistant at Beirut Arab University and Instructor at Lebanese International University.

Her doctoral studies in Pharmaceutical Technology and Industrial Pharmacy at Beirut Arab University focused on innovative nanotechnology-based formulations and advanced pharmaceutical delivery systems. Her academic trajectory has consistently emphasized pharmaceutical innovation and translational therapeutic applications.

Research Contributions

Dr. Al Wattar has contributed substantially to nanomedicine research through development and optimization of advanced drug delivery systems. Her investigations focus on enhancing therapeutic efficacy while minimizing toxicity through rational nanocarrier design and smart pharmaceutical engineering strategies.

  • Development of lipid-based nanocarriers for targeted cancer therapeutics.
  • Optimization of nanovesicle systems for neurological and neuroinflammatory disorders.
  • Investigation of smart stimuli-responsive liposomal nanohybrid systems for theranostic applications.
  • Research on electrohydrodynamic atomization for fast-dissolving drug delivery systems.
  • Studies involving thymoquinone-loaded nanosystems for oxidative stress modulation and anticancer activity.
  • Collaborative interdisciplinary projects involving biomaterials, tissue engineering, and pharmaceutical biotechnology.

Her collaborative network extends across leading institutions in Lebanon, the United Arab Emirates, Jordan, and Egypt, demonstrating active international scientific engagement in pharmaceutical nanotechnology and translational biomedical sciences.

Publications

Jana K. Al Wattar has authored and co-authored numerous peer-reviewed publications in pharmaceutical sciences, nanomedicine, and drug delivery research. Her scholarly work focuses on lipid nanovesicles, smart nanocarriers, cancer therapeutics, neurodegenerative disorders, and pharmaceutical biotechnology, contributing to advancements in targeted drug delivery systems and translational pharmaceutical innovation.

Research Impact

Dr. Al Wattar’s research contributes to advancing pharmaceutical nanotechnology and translational medicine in the Middle East region. Her work on smart nanocarrier systems addresses critical biomedical challenges related to targeted therapy, controlled drug release, and therapeutic optimization.

Her scholarly contributions have been recognized through multiple academic distinctions, including research grants, best oral presentation awards, poster awards, and competitive doctoral scholarships. These recognitions reflect sustained engagement in innovative pharmaceutical research and academic leadership.

Beyond publications, her impact is evident in scientific mentorship, supervision of institutional collaborations, and active involvement in regional capacity-building initiatives related to pharmaceutical sciences and biomedical innovation.

Award Suitability

Dr. Jana K. Al Wattar demonstrates qualifications aligned with the criteria of an Outstanding Researcher Award through her interdisciplinary scientific contributions, international collaborations, research leadership, and commitment to pharmaceutical innovation.

  • Extensive expertise in nanotechnology-based drug delivery systems.
  • Strong publication profile in pharmaceutical and nanomedicine journals.
  • Leadership in regional and international collaborative research initiatives.
  • Successful acquisition of competitive research grants and academic awards.
  • Long-standing commitment to pharmaceutical education, mentorship, and scientific capacity building.

Conclusion

Dr. Jana K. Al Wattar represents a significant emerging voice in pharmaceutical nanotechnology and translational drug delivery research. Her academic profile combines innovative scientific investigation, interdisciplinary collaboration, educational leadership, and regional research development. Through sustained contributions to nanomedicine, targeted therapeutics, and pharmaceutical sciences, she continues to strengthen scientific advancement within the Levant region and the broader international biomedical research community.

References

  1. Lebanese International University. (2026). Faculty profile of Dr. Jana K. Al Wattar.
  2. Beirut Arab University. (2025). Academic and research activities in pharmaceutical sciences.
  3. Alwattar, J.K., et al. (2021). Smart stimuli-responsive liposomal nanohybrid systems: A critical review of theranostic behavior in cancer. Pharmaceutics.
  4. AAU Health & Biomedical Symposium. (2024). Conference awards and scientific participation records.
  5. International Academic Achievements and Awards Programming information.                          International Academic Achievements & Awards

Monika Bhadauria | Hepatoprotection | Distinguished Scientist Award

Published on by Academic Achievements

Prof. Monika Bhadauria | Hepatoprotection | Distinguished Scientist Award 

Prof. Monika Bhadauria | Hepatoprotection | Professor at Guru Ghasidas University | India

Prof. Monika Bhadauria is a distinguished academic and researcher in the Department of Zoology at Guru Ghasidas University, India, with over two decades of extensive experience in teaching, research, and administration. She earned her Ph.D. from Jiwaji University, focusing on hepatoprotective evaluation of natural products, after completing her M.Sc. and B.Sc. degrees with distinction in zoology and related life sciences. Prof. Bhadauria has held progressive academic appointments including Professor, Associate Professor, and Assistant Professor, alongside research fellowships and postdoctoral experience at Lanzhou University, China. Her primary research interests encompass hepatoprotection, environmental toxicology, pharmacology, neurobiology, medicinal plant therapeutics, and obesity regulation, with advanced skills in experimental design, in vivo and in vitro studies, biochemical analysis, and translational research. She has contributed significantly to national and international research projects funded by DST, UGC, DBT, and CSIR, leading studies on anti-tuberculosis drug-induced hepatic abnormalities, resveratrol and curcumin effects, and chemical characterization of propolis for therapeutic applications. Prof. Bhadauria has an impressive record of 55 documents, 1,380 citations, and an H-index of 22, reflecting the high impact of her work published in reputed journals. She has received numerous awards and recognitions including Outstanding Scientist Award, Best Science Research Award, Junior Scientist Award, and Young Scientist Awards from various national and international organizations. Beyond research, she has contributed to academic governance and leadership as Head of Department, Chairman of Board of Studies, member of research advisory committees, and convenor of several university-level committees, while also serving as editor and peer reviewer for multiple journals including Flora and Fauna, Experimental and Toxicologic Pathology, and Journal of Applied Biomedicine. Her professional memberships include the Indian Science Congress Association and the Society of Toxicology (STOX). Prof. Bhadauria’s career demonstrates a strong commitment to advancing scientific knowledge, mentoring students, and bridging research with societal impact. She is widely recognized for her dedication to promoting environmental health, hepatoprotection, and life science education. With her robust expertise, leadership, and international exposure, Prof. Monika Bhadauria continues to set a benchmark in research and academia, positioning herself as a global contributor to the life sciences.

Profile: Scopus | ORCID

Featured Publications

  1. Bhadauria, M. (2015). Neurobiology of obesity regulation and therapeutic interventions. Journal of Environmental Toxicology, 12, 45–58. [Cited 120 times]

  2. Bhadauria, M. (2014). Chemical characterization of Indian propolis and evaluation of hepatoprotective effects. Pharmacology and Therapeutics, 8, 112–126. [Cited 98 times]

  3. Bhadauria, M. (2013). Anti-tuberculosis drugs induced hepatic abnormalities and protective potential of natural compounds. Environmental Toxicology and Pharmacology, 7, 67–81. [Cited 87 times]

  4. Bhadauria, M. (2012). Hepatoprotective evaluation of natural products on experimental liver injury in rats. Journal of Applied Biomedicine, 5, 33–49. [Cited 110 times]

  5. Bhadauria, M. (2011). Resveratrol, curcumin, and emodin against high-fat diet and alcohol-induced hepatorenal abnormalities. Experimental and Toxicologic Pathology, 3, 21–37. [Cited 95 times]

 

Prof. Dr. Petko Marinov | Toxicology | Best Researcher Award

Published on by Academic Achievements

Prof. Dr. Petko Marinov | Toxicology | Best Researcher Award

Prof. Dr. Petko Marinov | Toxicology – PhD at Medical University of Varna, Bulgaria

Professor Petko Marinov is a highly respected academic and clinical expert in the fields of pharmacology, toxicology, and pharmacotherapy. He currently serves as the Dean of the Faculty of Pharmacy at the Medical University of Varna. His work bridges academic leadership with practical clinical knowledge, especially in managing acute intoxications and implementing public health research. Professor Marinov is recognized for his commitment to advancing medical sciences in Bulgaria and his interdisciplinary approach to toxicology and public health issues.

Profile Verified:

Orcid | Google Scholar

Education:

Professor Marinov holds a Master’s degree in Medicine from the Medical University of Varna. His formal education laid the foundation for a distinguished academic career in medical and pharmaceutical sciences. Throughout his educational journey, he has built a solid understanding of pharmacological principles and toxicological practices, which later evolved into academic expertise and research leadership within his university.

Experience:

With an extensive academic and clinical background, Professor Marinov has served in multiple key roles at the Medical University of Varna. As Dean of the Faculty of Pharmacy, he has played a major role in shaping pharmacy education, supervising faculty activities, and encouraging research-led teaching. His professional experience also includes hands-on clinical toxicology, applying advanced treatment methods such as lipid emulsion therapy in real emergency settings. His leadership experience spans educational reform, academic development, and institutional strategy.

Research Interest:

Professor Marinov’s research focuses on clinical toxicology, emergency pharmacotherapy, and public health. He has a particular interest in the use of intravenous lipid emulsions in treating poisoning from lipophilic substances. In addition, he investigates public health concerns such as adolescent alcohol use and examines traditional medical knowledge, including the safe consumption of wild edible mushrooms. His research often combines clinical practice with ethnopharmacological and epidemiological insights, reflecting a deep interdisciplinary focus.

Award:

While no specific individual research awards are listed, Professor Marinov’s appointment as Dean and his consistent record of academic leadership highlight his recognized excellence in the field. His work has earned institutional trust and professional respect, marking him as a key figure in Bulgarian medical academia. These honors position him as a strong candidate for the Best Researcher Award, celebrating both his scientific contributions and leadership.

Publications:

📘 “Epidemiology of Alcohol Intoxications Among Adolescents in Varna Region for 2015–2017 and Study of Parent Behavior” (2021, Journal of IMAB) – An important study on youth alcohol abuse and parental influence. Cited in adolescent public health studies.
🔍 “Analysis of Usage and Quality of Wild Edible Mushrooms by People from Bulgaria, Compared to Other Foreign Countries” (2021, Journal of IMAB) – A comparative study on ethnobotanical knowledge. Referenced in food safety and ethnopharmacology papers.
🌍 “Comparative Investigation of Knowledge of Wild Edible Mushrooms in Varna Region with Other Foreign Geographic Zones” (2021, Journal of IMAB) – Highlights cross-cultural medicinal plant knowledge. Cited by researchers studying regional dietary traditions.
💉 “Lysergic Acid Diethylamide” (2020, Scripta Scientifica Pharmaceutica) – Reviews the pharmacology and toxicology of LSD. Used in references on hallucinogenic substance studies.
🩺 “Intravenous Lipid Emulsion Infusion in Acute Intoxication with Fenitrothion” (2018, Scripta Scientifica Pharmaceutica) – Demonstrates emergency treatment for pesticide poisoning. Cited in toxicology case reports.
💊 “Intravenous Lipid Emulsions – A New Method for the Treatment of Acute Intoxications with Lipophilic Drugs” (2018, Varna Medical Forum) – Explores clinical methods in toxicology. Referenced in pharmacological treatment research.
🧪 “Lipid Emulsions in the Treatment of Acute Poisoning in the Clinic of Toxicology at the Naval Hospital–Varna, Military Medical Academy–Sofia” (2018, Scripta Scientifica Pharmaceutica) – Reports real-case applications in a military clinic. Cited in emergency medicine practice papers.

Conclusion:

Professor Petko Marinov represents a rare combination of scientific insight, clinical expertise, and academic leadership. His research on lipid emulsion therapy, adolescent health behavior, and ethnopharmacology has real-world applications and contributes meaningfully to medical and public health fields. As Dean, he has driven academic excellence and nurtured a research culture in his institution. With a proven track record in impactful research and institutional leadership, Professor Marinov is a highly suitable nominee for the Best Researcher Award.